Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 419

1.

Picalm reduction exacerbates tau pathology in a murine tauopathy model.

Ando K, De Decker R, Vergara C, Yilmaz Z, Mansour S, Suain V, Sleegers K, de Fisenne MA, Houben S, Potier MC, Duyckaerts C, Watanabe T, Buée L, Leroy K, Brion JP.

Acta Neuropathol. 2020 Jan 10. doi: 10.1007/s00401-020-02125-x. [Epub ahead of print]

PMID:
31925534
2.

Prion-like properties of Tau assemblies.

Clavaguera F, Duyckaerts C, Haïk S.

Curr Opin Neurobiol. 2020 Jan 7;61:49-57. doi: 10.1016/j.conb.2019.11.022. [Epub ahead of print] Review.

PMID:
31923760
3.

Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms.

Huin V, Barbier M, Bottani A, Lobrinus JA, Clot F, Lamari F, Chat L, Rucheton B, Fluchère F, Auvin S, Myers P, Gelot A, Camuzat A, Caillaud C, Jornéa L, Forlani S, Saracino D, Duyckaerts C, Brice A, Durr A, Le Ber I.

Brain. 2020 Jan 1;143(1):303-319. doi: 10.1093/brain/awz377.

PMID:
31855245
4.

Human subiculo-fornico-mamillary system in Alzheimer's disease: Tau seeding by the pillar of the fornix.

Thierry M, Boluda S, Delatour B, Marty S, Seilhean D; Brainbank Neuro-CEB Neuropathology Network, Potier MC, Duyckaerts C.

Acta Neuropathol. 2019 Dec 10. doi: 10.1007/s00401-019-02108-7. [Epub ahead of print]

PMID:
31822997
5.

From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy.

Colin M, Dujardin S, Schraen-Maschke S, Meno-Tetang G, Duyckaerts C, Courade JP, Buée L.

Acta Neuropathol. 2020 Jan;139(1):3-25. doi: 10.1007/s00401-019-02087-9. Epub 2019 Nov 4. Review.

6.

Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.

Riku Y, Duyckaerts C, Boluda S, Plu I, Le Ber I, Millecamps S, Salachas F; Brainbank NeuroCEB Neuropathology Network, Yoshida M, Ando T, Katsuno M, Sobue G, Seilhean D.

Acta Neuropathol. 2019 Nov;138(5):783-793. doi: 10.1007/s00401-019-02028-6. Epub 2019 May 29.

PMID:
31144027
7.

Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7.

Coarelli G, Schule R, van de Warrenburg BPC, De Jonghe P, Ewenczyk C, Martinuzzi A, Synofzik M, Hamer EG, Baets J, Anheim M, Schöls L, Deconinck T, Masrori P, Fontaine B, Klockgether T, D'Angelo MG, Monin ML, De Bleecker J, Migeotte I, Charles P, Bassi MT, Klopstock T, Mochel F, Ollagnon-Roman E, D'Hooghe M, Kamm C, Kurzwelly D, Papin M, Davoine CS, Banneau G, Tezenas du Montcel S, Seilhean D, Brice A, Duyckaerts C, Stevanin G, Durr A.

Neurology. 2019 Jun 4;92(23):e2679-e2690. doi: 10.1212/WNL.0000000000007606. Epub 2019 May 8.

PMID:
31068484
8.

Expanding the spectrum of HIV-associated myopathy.

Landon-Cardinal O, Gallay L, Dubourg O, Maisonobe T, Léonard-Louis S, Beniken D, Simon A, Behin A, Stojkovic T, Duyckaerts C, Breton G, Rigolet A, Fain O, Meyohas MC, Leport C, Valantin MA, Vittecoq D, Bergmann JF, Hanslik T, Chauveheid MP, Amoura Z, de Broucker T, Eymard B, Beaudequin N, Benveniste O, Allenbach Y.

J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1296-1298. doi: 10.1136/jnnp-2018-319419. Epub 2019 Apr 11. No abstract available.

PMID:
30975823
9.

The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease.

Duyckaerts C, Clavaguera F, Potier MC.

Curr Opin Neurol. 2019 Apr;32(2):266-271. doi: 10.1097/WCO.0000000000000672. Review.

PMID:
30724769
10.

Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex.

Parodi L, Fenu S, Barbier M, Banneau G, Duyckaerts C, Tezenas du Montcel S, Monin ML, Ait Said S, Guegan J, Tallaksen CME, Sablonniere B, Brice A, Stevanin G, Depienne C, Durr A; SPATAX network.

Brain. 2018 Dec 1;141(12):3331-3342. doi: 10.1093/brain/awy285.

PMID:
30476002
11.

Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity?

Chartier S, Duyckaerts C.

Cell Tissue Res. 2018 Jul;373(1):149-160. doi: 10.1007/s00441-018-2854-6. Epub 2018 Jun 5. Review.

PMID:
29869713
12.

Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias.

Fournier C, Anquetil V, Camuzat A, Stirati-Buron S, Sazdovitch V, Molina-Porcel L, Turbant S, Rinaldi D, Sánchez-Valle R, Barbier M, Latouche M; Neuro-CEB Neuropathology Network, Stevanin G, Seilhean D, Brice A, Duyckaerts C, Le Ber I.

Acta Neuropathol Commun. 2018 May 30;6(1):41. doi: 10.1186/s40478-018-0547-8. No abstract available.

13.

Influence of Lewy Pathology on Alzheimer's Disease Phenotype: A Retrospective Clinico-Pathological Study.

Roudil J, Deramecourt V, Dufournet B, Dubois B, Ceccaldi M, Duyckaerts C, Pasquier F, Lebouvier T; Brainbank Neuro-CEB Neuropathology Network.

J Alzheimers Dis. 2018;63(4):1317-1323. doi: 10.3233/JAD-170914.

14.

Evidence for altered dendritic spine compartmentalization in Alzheimer's disease and functional effects in a mouse model.

Androuin A, Potier B, Nägerl UV, Cattaert D, Danglot L, Thierry M, Youssef I, Triller A, Duyckaerts C, El Hachimi KH, Dutar P, Delatour B, Marty S.

Acta Neuropathol. 2018 Jun;135(6):839-854. doi: 10.1007/s00401-018-1847-6. Epub 2018 Apr 25.

PMID:
29696365
15.

Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer's disease brain.

Dominguez G, Maddelein ML, Pucelle M, Nicaise Y, Maurage CA, Duyckaerts C, Cuvillier O, Delisle MB.

Acta Neuropathol Commun. 2018 Apr 3;6(1):25. doi: 10.1186/s40478-018-0527-z.

16.

Amyloid Angiopathy in Brain Hemorrhage: A Postmortem Neuropathological-Magnetic Resonance Imaging Study.

Guidoux C, Hauw JJ, Klein IF, Labreuche J, Berr C, Duyckaerts C, Amarenco P.

Cerebrovasc Dis. 2018;45(3-4):124-131. doi: 10.1159/000486554. Epub 2018 Mar 20.

PMID:
29558742
17.

Fatal Aβ cerebral amyloid angiopathy 4 decades after a dural graft at the age of 2 years.

Hervé D, Porché M, Cabrejo L, Guidoux C, Tournier-Lasserve E, Nicolas G, Adle-Biassette H, Plu I, Chabriat H, Duyckaerts C.

Acta Neuropathol. 2018 May;135(5):801-803. doi: 10.1007/s00401-018-1828-9. Epub 2018 Mar 5. No abstract available.

PMID:
29508058
18.

3D imaging in the postmortem human brain with CLARITY and CUBIC.

Ando K, Laborde Q, Brion JP, Duyckaerts C.

Handb Clin Neurol. 2018;150:303-317. doi: 10.1016/B978-0-444-63639-3.00021-9.

PMID:
29496149
19.

New clinicopathological associations and histoprognostic markers in ILAE types of hippocampal sclerosis.

Calderon-Garcidueñas AL, Mathon B, Lévy P, Bertrand A, Mokhtari K, Samson V, Thuriès V, Lambrecq V, Nguyen VM, Dupont S, Adam C, Baulac M, Clémenceau S, Duyckaerts C, Navarro V, Bielle F.

Brain Pathol. 2018 Sep;28(5):644-655. doi: 10.1111/bpa.12596. Epub 2018 Apr 10. Erratum in: Brain Pathol. 2019 Jul;29(4):584.

PMID:
29476662
20.

Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement.

Allenbach Y, Arouche-Delaperche L, Preusse C, Radbruch H, Butler-Browne G, Champtiaux N, Mariampillai K, Rigolet A, Hufnagl P, Zerbe N, Amelin D, Maisonobe T, Louis-Leonard S, Duyckaerts C, Eymard B, Goebel HH, Bergua C, Drouot L, Boyer O, Benveniste O, Stenzel W.

Neurology. 2018 Feb 6;90(6):e507-e517. doi: 10.1212/WNL.0000000000004923. Epub 2018 Jan 12.

PMID:
29330311
21.

Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study.

Cali I, Cohen ML, Haik S, Parchi P, Giaccone G, Collins SJ, Kofskey D, Wang H, McLean CA, Brandel JP, Privat N, Sazdovitch V, Duyckaerts C, Kitamoto T, Belay ED, Maddox RA, Tagliavini F, Pocchiari M, Leschek E, Appleby BS, Safar JG, Schonberger LB, Gambetti P.

Acta Neuropathol Commun. 2018 Jan 8;6(1):5. doi: 10.1186/s40478-017-0503-z.

22.

Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology.

Duyckaerts C, Sazdovitch V, Ando K, Seilhean D, Privat N, Yilmaz Z, Peckeu L, Amar E, Comoy E, Maceski A, Lehmann S, Brion JP, Brandel JP, Haïk S.

Acta Neuropathol. 2018 Feb;135(2):201-212. doi: 10.1007/s00401-017-1791-x. Epub 2017 Nov 22.

PMID:
29209767
23.

Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009.

Peckeu L, Delasnerie-Lauprètre N, Brandel JP, Salomon D, Sazdovitch V, Laplanche JL, Duyckaerts C, Seilhean D, Haïk S, Hauw JJ.

Euro Surveill. 2017 Oct;22(41). doi: 10.2807/1560-7917.ES.2017.22.41.16-00715.

24.

Alzheimer disease.

Calderon-Garcidueñas AL, Duyckaerts C.

Handb Clin Neurol. 2017;145:325-337. doi: 10.1016/B978-0-12-802395-2.00023-7. Review.

PMID:
28987180
25.

Amygdala TDP-43 Pathology in Frontotemporal Lobar Degeneration and Motor Neuron Disease.

Takeda T, Seilhean D, Le Ber I, Millecamps S, Sazdovitch V, Kitagawa K, Uchihara T, Duyckaerts C.

J Neuropathol Exp Neurol. 2017 Sep 1;76(9):800-812. doi: 10.1093/jnen/nlx063.

PMID:
28859337
26.

Chemically-defined camelid antibody bioconjugate for the magnetic resonance imaging of Alzheimer's disease.

Vandesquille M, Li T, Po C, Ganneau C, Lenormand P, Dudeffant C, Czech C, Grueninger F, Duyckaerts C, Delatour B, Dhenain M, Lafaye P, Bay S.

MAbs. 2017 Aug/Sep;9(6):1016-1027. doi: 10.1080/19420862.2017.1342914. Epub 2017 Jun 28.

27.

Predictive factors of long-term outcomes of surgery for mesial temporal lobe epilepsy associated with hippocampal sclerosis.

Mathon B, Bielle F, Samson S, Plaisant O, Dupont S, Bertrand A, Miles R, Nguyen-Michel VH, Lambrecq V, Calderon-Garcidueñas AL, Duyckaerts C, Carpentier A, Baulac M, Cornu P, Adam C, Clemenceau S, Navarro V.

Epilepsia. 2017 Aug;58(8):1473-1485. doi: 10.1111/epi.13831. Epub 2017 Jun 28.

28.

Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).

Kovacs GG, Xie SX, Lee EB, Robinson JL, Caswell C, Irwin DJ, Toledo JB, Johnson VE, Smith DH, Alafuzoff I, Attems J, Bencze J, Bieniek KF, Bigio EH, Bodi I, Budka H, Dickson DW, Dugger BN, Duyckaerts C, Ferrer I, Forrest SL, Gelpi E, Gentleman SM, Giaccone G, Grinberg LT, Halliday GM, Hatanpaa KJ, Hof PR, Hofer M, Hortobágyi T, Ironside JW, King A, Kofler J, Kövari E, Kril JJ, Love S, Mackenzie IR, Mao Q, Matej R, McLean C, Munoz DG, Murray ME, Neltner J, Nelson PT, Ritchie D, Rodriguez RD, Rohan Z, Rozemuller A, Sakai K, Schultz C, Seilhean D, Smith V, Tacik P, Takahashi H, Takao M, Rudolf Thal D, Weis S, Wharton SB, White CL 3rd, Woulfe JM, Yamada M, Trojanowski JQ.

J Neuropathol Exp Neurol. 2017 Jul 1;76(7):605-619. doi: 10.1093/jnen/nlx041.

29.

Alzheimer's senile plaque as shown by microcryodissection, a new technique for dissociating tissue structures.

Thierry M, Marty S, Boluda S, Duyckaerts C.

J Neural Transm (Vienna). 2017 Jun;124(6):685-694. doi: 10.1007/s00702-017-1718-7. Epub 2017 Apr 6.

PMID:
28386671
30.

Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking.

Doucet M, Becker KF, Björkman J, Bonnet J, Clément B, Daidone MG, Duyckaerts C, Erb G, Haslacher H, Hofman P, Huppertz B, Junot C, Lundeberg J, Metspalu A, Lavitrano M, Litton JE, Moore HM, Morente M, Naimi BY, Oelmueller U, Ollier B, Parodi B, Ruan L, Stanta G, Turano P, Vaught J, Watson P, Wichmann HE, Yuille M, Zaomi M, Zatloukal K, Dagher G.

Biopreserv Biobank. 2017 Jun;15(3):270-276. doi: 10.1089/bio.2016.0053. Epub 2016 Dec 19. No abstract available.

31.

Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets.

Li T, Vandesquille M, Koukouli F, Dudeffant C, Youssef I, Lenormand P, Ganneau C, Maskos U, Czech C, Grueninger F, Duyckaerts C, Dhenain M, Bay S, Delatour B, Lafaye P.

J Control Release. 2016 Dec 10;243:1-10. doi: 10.1016/j.jconrel.2016.09.019. Epub 2016 Oct 6.

32.

Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co-deleted anaplastic gliomas.

Bielle F, Ducray F, Mokhtari K, Dehais C, Adle-Biassette H, Carpentier C, Chanut A, Polivka M, Poggioli S, Rosenberg S, Giry M, Marie Y, Duyckaerts C, Sanson M, Figarella-Branger D, Idbaih A; Pola Network.

Brain Pathol. 2017 Sep;27(5):567-579. doi: 10.1111/bpa.12434. Epub 2016 Oct 28.

PMID:
27543943
33.

The MAPT gene is differentially methylated in the progressive supranuclear palsy brain.

Huin V, Deramecourt V, Caparros-Lefebvre D, Maurage CA, Duyckaerts C, Kovari E, Pasquier F, Buée-Scherrer V, Labreuche J, Behal H, Buée L, Dhaenens CM, Sablonnière B.

Mov Disord. 2016 Dec;31(12):1883-1890. doi: 10.1002/mds.26820. Epub 2016 Oct 6.

PMID:
27709663
34.

Caspase-cleaved Tau-D(421) is colocalized with the immunophilin FKBP52 in the autophagy-endolysosomal system of Alzheimer's disease neurons.

Meduri G, Guillemeau K, Dounane O, Sazdovitch V, Duyckaerts C, Chambraud B, Baulieu EE, Giustiniani J.

Neurobiol Aging. 2016 Oct;46:124-37. doi: 10.1016/j.neurobiolaging.2016.06.017. Epub 2016 Jul 5.

PMID:
27479154
35.

Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.

Papegaey A, Eddarkaoui S, Deramecourt V, Fernandez-Gomez FJ, Pantano P, Obriot H, Machala C, Anquetil V, Camuzat A, Brice A, Maurage CA, Le Ber I, Duyckaerts C, Buée L, Sergeant N, Buée-Scherrer V.

Acta Neuropathol Commun. 2016 Jul 19;4(1):74. doi: 10.1186/s40478-016-0345-0.

36.

The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.

De Vos A, Struyfs H, Jacobs D, Fransen E, Klewansky T, De Roeck E, Robberecht C, Van Broeckhoven C, Duyckaerts C, Engelborghs S, Vanmechelen E.

J Alzheimers Dis. 2016 Jul 6;53(4):1523-38. doi: 10.3233/JAD-160227.

37.

Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.

Ando K, Tomimura K, Sazdovitch V, Suain V, Yilmaz Z, Authelet M, Ndjim M, Vergara C, Belkouch M, Potier MC, Duyckaerts C, Brion JP.

Neurobiol Dis. 2016 Oct;94:32-43. doi: 10.1016/j.nbd.2016.05.017. Epub 2016 May 31.

PMID:
27260836
38.

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O'Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CR Jr; Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on “The Preclinical State of AD”; July 23, 2015; Washington DC, USA.

Alzheimers Dement. 2016 Mar;12(3):292-323. doi: 10.1016/j.jalz.2016.02.002. Review.

39.

Dural and osteolytic sarcomatoid relapse of a secondary gliosarcoma with tryptase immunoreactivity.

Calderon-Garcidueñas AL, Idbaih A, Galanaud D, Duyckaerts C, Bielle F.

Clin Neuropathol. 2016 May-Jun;35(3):154-8. doi: 10.5414/NP300916. No abstract available.

PMID:
26784965
40.

Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.

Eisele YS, Duyckaerts C.

Acta Neuropathol. 2016 Jan;131(1):5-25. doi: 10.1007/s00401-015-1516-y. Epub 2015 Dec 29. Review.

PMID:
26715565
41.

Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobágyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kövari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemüller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL 3rd, Wisniewski T, Woulfe JM, Yamada M, Dickson DW.

Acta Neuropathol. 2016 Jan;131(1):87-102. doi: 10.1007/s00401-015-1509-x. Epub 2015 Dec 10. Review.

42.

[Spreading of protein misfolding: A new paradigm in neurology].

Hauw JJ, Haïk S, Duyckaerts C.

Rev Neurol (Paris). 2015 Dec;171(12):825-31. doi: 10.1016/j.neurol.2015.09.010. Epub 2015 Nov 11. Review. French.

PMID:
26573331
43.

Coronary and Basilar Artery Ectasia Are Associated: Results From an Autopsy Case-Control Study.

Pico F, Labreuche J, Hauw JJ, Seilhean D, Duyckaerts C, Amarenco P.

Stroke. 2016 Jan;47(1):224-7. doi: 10.1161/STROKEAHA.115.010797. Epub 2015 Oct 29.

PMID:
26514190
44.

A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia.

Coutelier M, Blesneac I, Monteil A, Monin ML, Ando K, Mundwiller E, Brusco A, Le Ber I, Anheim M, Castrioto A, Duyckaerts C, Brice A, Durr A, Lory P, Stevanin G.

Am J Hum Genet. 2015 Nov 5;97(5):726-37. doi: 10.1016/j.ajhg.2015.09.007. Epub 2015 Oct 8.

45.

Extensive brain demyelinating lesions under natalizumab: The role of anti-natalizumab antibodies.

Debs R, Maillart E, Fahed R, Papeix C, Duyckaerts C, Stadelmann C, Galanaud D, Lubetzki C.

Neurology. 2015 Nov 3;85(18):1630-2. doi: 10.1212/WNL.0000000000002084. Epub 2015 Oct 9. No abstract available.

PMID:
26453649
46.

Progressive Supranuclear Palsy Syndrome and Semantic Dementia in Neuropathologically Proven Lewy Body Disease: A Report of Two Cases.

Lagarde J, Hamelin L, Hahn V, Habert MO, Seilhean D, Duyckaerts C, Sarazin M.

J Alzheimers Dis. 2015;47(1):95-101. doi: 10.3233/JAD-150203.

PMID:
26402758
47.

Modifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer's disease patients.

Corlier F, Rivals I, Lagarde J, Hamelin L, Corne H, Dauphinot L, Ando K, Cossec JC, Fontaine G, Dorothée G, Malaplate-Armand C, Olivier JL, Dubois B, Bottlaender M, Duyckaerts C, Sarazin M, Potier MC; Clinical ImaBio3 Team.

Transl Psychiatry. 2015 Jul 7;5:e595. doi: 10.1038/tp.2015.87.

48.

CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.

Djelti F, Braudeau J, Hudry E, Dhenain M, Varin J, Bièche I, Marquer C, Chali F, Ayciriex S, Auzeil N, Alves S, Langui D, Potier MC, Laprevote O, Vidaud M, Duyckaerts C, Miles R, Aubourg P, Cartier N.

Brain. 2015 Aug;138(Pt 8):2383-98. doi: 10.1093/brain/awv166. Epub 2015 Jul 2.

PMID:
26141492
49.

Seeding and propagation of lesions in neurodegenerative diseases: a new paradigm.

Duyckaerts C, Seilhean D, Sazdovitch V, Plu I, Delatour B, Potier MC.

Bull Acad Natl Med. 2015 Jun;199(6):809-819.

PMID:
29901881
50.

TDP-43 Pathology Progression Along the Olfactory Pathway as a Possible Substrate for Olfactory Impairment in Amyotrophic Lateral Sclerosis.

Takeda T, Iijima M, Uchihara T, Ohashi T, Seilhean D, Duyckaerts C, Uchiyama S.

J Neuropathol Exp Neurol. 2015 Jun;74(6):547-56. doi: 10.1097/NEN.0000000000000198.

PMID:
25933387

Supplemental Content

Loading ...
Support Center